{"Ticker": "HCA", "Company": "HCA Healthcare", "Sector": "Health Care", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$240"}, {"Date": "2022-05-27", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$273 to $271"}, {"Date": "2022-03-29", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$267"}, {"Date": "2022-01-10", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$274 to $306"}, {"Date": "2021-12-21", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$270"}, {"Date": "2021-09-27", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": "$320"}, {"Date": "2021-09-24", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$312"}, {"Date": "2021-09-10", "Rating": "Initiated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$293"}, {"Date": "2021-08-12", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$275 to $267"}, {"Date": "2021-07-09", "Rating": "Initiated", "Organization": "Seaport Global Securities", "Rating_Change": "Buy", "Target_Change": "$235"}, {"Date": "2021-05-13", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$215"}, {"Date": "2021-04-26", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$191 to $215"}, {"Date": "2020-12-15", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$191"}, {"Date": "2020-12-14", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$194"}, {"Date": "2020-09-21", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$161 to $143"}, {"Date": "2020-07-13", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$100"}, {"Date": "2019-09-06", "Rating": "Upgrade", "Organization": "BofA/Merrill", "Rating_Change": "Underperform to Neutral", "Target_Change": "$130 to $137"}, {"Date": "2019-07-10", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$147 to $160"}, {"Date": "2019-04-23", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": ""}, {"Date": "2019-01-14", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Overweight", "Target_Change": "$143"}, {"Date": "2019-01-03", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$140"}, {"Date": "2018-11-16", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$162"}, {"Date": "2018-03-23", "Rating": "Resumed", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$115"}, {"Date": "2018-01-03", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": ""}]}